Interaction between human serum esterases and environmental metal compounds

NeuroToxicology

Volumn 30, Issue 4, 2009, Pages 628-635

  Hernández, Antonio F ^a   Gil, Fernando ^a   Leno, Esther ^a   López, Olga ^a   Rodrigo, Lourdes ^a   Pla, Antonio ^a  

^a UNIVERSITY OF GRANADA   (Spain)

Author keywords

Cholinesterase; Environmental health; Metal compounds; PON1; Serum esterases

Indexed keywords

ARSENIC; ARYLDIALKYLPHOSPHATASE 1; CADMIUM; CHOLINESTERASE; DIAZOXON; DIHYDROCOUMARIN; ESTERASE; HEAVY METAL; LEAD; MANGANESE; MERCURY; NICKEL; PARAOXON; PHENYLACETIC ACID; UNCLASSIFIED DRUG; ZINC;

ADOLESCENT; ADULT; AGE; AGED; ALCOHOL CONSUMPTION; ARTICLE; ATOMIC ABSORPTION SPECTROMETRY; BLOOD ANALYSIS; BODY MASS; CHILD; CIGARETTE SMOKING; CONTROLLED STUDY; EATING HABIT; ENVIRONMENTAL EXPOSURE; ENZYME ACTIVITY; FEMALE; GENETIC VARIABILITY; HUMAN; LEAD BLOOD LEVEL; LIFESTYLE; MALE; NORMAL HUMAN; PREDICTION; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN INTERACTION; SCHOOL CHILD; SEX DIFFERENCE; SPAIN;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ARYLDIALKYLPHOSPHATASE; CARBOXYLIC ESTER HYDROLASES; CHILD; CROSS-SECTIONAL STUDIES; ESTERASES; FEMALE; HUMANS; LINEAR MODELS; MALE; METALS; MIDDLE AGED; SPAIN; STATISTICS, NONPARAMETRIC; YOUNG ADULT;

EID: 67651000009     PISSN: 0161813X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuro.2009.04.003     Document Type: Article

References (33)

1. Browne R.O., Moyal-Segal L.B., Zumsteg D., David Y., Kofman O., Berger A., et al. Coding region paraoxonase polymorphisms dictate accentuated neuronal reactions in chronic, sub-threshold pesticide exposure. FASEB J 20 (2006) 1733-1735
2. Çokugras A.N., Cengiz D., and Tezcan E.F. The effects of Ni, Co, and Mn on human serum butyrylcholinesterase. J Protein Chem 22 (2003) 585-589
3. Cole T.B., Li W.F., Richter R.J., Furlong C.E., and Costa L.G. Inhibition of paraoxonase (PON1) by heavy metals. Toxicol Sci 66 1S (2002) 312
4. Costa L.G., Vitalone A., Cole T.B., and Furlong C.E. Modulation of paraoxonase (PON1) activity. Biochem Pharmacol 69 (2005) 541-550
5. Debord J., Bollinger J.C., Merle L., and Dantoine T. Inhibition of human serum arylesterase by metal chlorides. J Inorg Biochem 94 (2003) 1-4
6. Draganov D.I., Stetson P.L., Watson C.E., Billecke S.S., and La Du B.N. Rabbit serum paraoxonase 3 (PON3) is a high density lipoprotein-associated lactonase and protects low density lipoprotein against oxidation. J Biol Chem 275 (2000) 33435-33442
7. Draganov D.I., and La Du B.N. Pharmacogenetics of paraoxonases: a brief review. Naunyn-Smiedeberǵs Arch Pharmacol 369 (2004) 78-88
8. Draganov D.I., Teiber J.F., Speelman A., Osawa Y., Sunahara R., and La Du B.N. Human paraoxonases (PON1, PON2 and PON3) are lactonases with overlapping and distinct substrate specificities. J Lipid Res 46 (2005) 1239-1247
9. Eckerson H.W., Wyte C.M., and La Du B.N. The human serum paraoxonase/arylesterase polymorphism. Am J Human Genet 35 (1983) 1126-1138
10. Furlong C.E. Genetic variability in the cytochrome P450-paraoxonase 1 (PON1) pathway for detoxication of organophosphorus compounds. J Biochem Mol Toxicol 21 (2007) 197-205
11. Gil F., Capitan-Vallvey L.F., De Santiago E., Ballesta J., Pla A., Hernández A.F., et al. Heavy metal concentrations in the general population of Andalusia, South of Spain A comparison with the population within the area of influence of Aznalcollar mine spill (SW Spain). Sci Total Environ 372 (2006) 49-57
12. Gómez Aracena J. La encuesta alimentaria como instrumento de evaluación del estado nutritivo de la comunidad. Doctoral Thesis. Universidad de Málaga; 1990.
13. Gonzalvo M.C., Gil F., Hernández A.F., Villanueva E., and Pla A. Inhibition of paraoxonase activity in human liver microsomes by exposure to EDTA, metals and mercurials. Chem Biol Interact. 105 (1997) 169-179
14. Harel M., Aharoni A., Gaidukov L., Brumshtein B., Khersonsky O., Meged R., et al. Structure and evolution of the serum paraoxonase family of detoxifying and anti-atherosclerotic enzymes. Nat Struct Mol Biol 11 (2004) 412-419
15. Heijmans B.T., Westendorp R.G., Lagaay A.M., Knook D.L., Kluft C., and Slagboom P.E. Common paraoxonase gene variants, mortality risk and fatal cardiovascular events in elderly subjects. Atherosclerosis 149 (2000) 91-97
16. Hernández A.F., Mackness B., Rodrigo L., López O., Pla A., Gil F., et al. Paraoxonase activity and genetic polymorphisms in greenhouse workers with long term pesticide exposure. Hum Exp Toxicol 22 (2003) 565-574
17. Hernández A.F., Gómez M.A., Pena G., Gil F., Rodrigo L., Villanueva E., et al. Effect of long-term exposure to pesticides on plasma esterases from plastic greenhouse workers. J Toxicol Environ Health A 67 (2004) 1095-1108
18. Hernández A.F., López O., Pena O., Serrano J.L., Parrón J.L., Rodrigo L., et al. Paraoxonase-1, (PON1) as a predictor of biochemical outcomes in farmers. Curr Enzyme Inhibit 3 (2007) 175-182
19. Josse D., Bartels C., Lockridge D., and Masson P. PON1 structure. In: Costa L.G., and Furlong C.E. (Eds). Paraoxonase (PON1) in health and disease: basic and clinical aspects (2002), Kluwer Academic Publishers, Norwell (MA) 27-52
20. Junge W., and Klees H. Arylesterase. In: Bergmeyer H.U., Bergmeyer J., and Graßi M. (Eds). Methods of enzymatic analysis vol. IV (1984), Verlag Chemie, Weinheim 8-14
21. Klevay L.M. Ischemic heart disease as deficiency disease. Cell Moll Biol (Noisy-le-grand) 50 (2004) 877-884
22. Klevay L.M. How dietary deficiency, genes and a toxin can cooperate to produce arteriosclerosis and ischemic heart disease. Cell Mol Biol (Noisy-le-grand) 52 (2006) 11-15
23. Li W.F., Pan M.H., Chung M.C., Ho C.K., and Chuang H.Y. Lead exposure is associated with decreased serum paraoxonase 1 (PON1) activity and genotypes. Environ Health Perspect 114 (2006) 1233-1236
24. Li B., Sedlacek M., Manoharan I., Boopathy R., Duysen E.G., Masson P., et al. Butyrylcholinesterase, paraoxonase, and albumin esterase but not carboxylesterase, are present in human plasma. Biochem Pharmacol 10 (2005) 1673-1684
25. Mackness B., Davies G.K., Turkie W., Lee E., Roberts D.H., Hill E., et al. Paraoxonase status in coronary heart disease: are activity and concentration more important than genotype?. Arterioscler Thromb Vasc Biol 21 (2001) 1451-1457
26. Nguyen S.D., and Sok D.E. Oxidative inactivation of paraoxonase1, an antioxidant protein and its effect on antioxidant action. Free Radic Res 37 (2003) 1319-1330
27. Nguyen S.D., Kim J.R., Kim M.R., Jung T.S., and Soka D.E. Copper ions and hypochlorite are mainly responsible for oxidative inactivation of paraoxon-hydrolyzing activity in human high density lipoprotein. Toxicol Lett 147 (2004) 201-208
28. Pla A., Rodrigo L., Hernández A.F., Gil F., and Lopez O. Effect of metal ions and calcium on purified PON1 and PON3 from rat liver. Chem-Biol Interact 167 (2007) 63-70
29. Richter R.J., and Furlong C.E. Determination of paraoxonase (PON1) status requires more than genotyping. Pharmacogenetics 9 (1999) 745-753
30. Rodrigo L., Hernández A.F., Lopez-Caballero J.J., Gil F., and Pla A. Immunohistochemical evidence for the expression and induction of paraoxonase in rat liver, kidney, lung and brain tissue. Implications for its physiological role. Chem-Biol Interact 137 (2001) 123-137
31. Shamir R., Hartman C., Karry R., Pavlotzky E., Eliakim R., Lachter J., et al. Paraoxonases (PONs) 1, 2 and 3 are expressed in human and mouse gastrointestinal tract in Caco-2 cell line: selective secretion of PON1 and PON2. Free Rad Biol Med 39 (2005) 336-344
32. Trudel K., Sinnett D., James R.W., Delvin E., Amre D., Seidman E., et al. Iron-ascorbic acid-induced oxidant stress and its quenching by paraoxonase 1 in HDL and the liver: comparison between humans and rats. J Cell Biochem 96 (2005) 404-411
33. Whittaker M. Cholinesterases. In: Bergmeyer H.U., Bergmeyer J., and Grassi M. (Eds). Methods of enzymatic analysis vol. IV (1984), Verlag Chemie, Weinheim 52-74